Incannex Healthcare Inc
Kalani Scarrott is a financial accountant currently working at Incannex Healthcare Limited since September 2023. Previous experience includes serving as a lifeguard at Broadspectrum from January 2020 to July 2024, a pioneer at Colossus from October 2020 to June 2021, and an assistant portfolio manager at The Dual Momentum Fund from April to June 2019, where responsibilities included managing $7 million in portfolio positions and maintaining a pricing and analytical database. Earlier in the career, Kalani was a document control officer at Australian Clinical Labs from January 2014 to July 2018, overseeing the online library of policies and procedures in compliance with audit standards. Kalani holds a Master of Finance from Curtin University (2019-2020) and a Bachelor's Degree in Accounting and Chinese from Curtin University (2014-2018).
This person is not in any teams
Incannex Healthcare Inc
Incannex is a clinical-stage pharmaceutical development company focused on discovering and developing life-changing medicines for patients struggling with serious, chronic diseases and limited treatment options. A leader in innovating proprietary cannabinoid pharmaceuticals and psychedelic-based therapies, we are developing medicines with the potential to alter the lives of patients suffering from obstructive sleep apnea (OSA), generalized anxiety disorder (GAD), and inflammatory disorders such as rheumatoid arthritis (RA). Working together in these relatively new fields with clinical, scientific, and drug development experts, we are efficiently innovating big solutions that are specifically designed and formulated to make a meaningful difference in patients’ lives. Founded in 2015 and headquartered in Melbourne, Australia, we are expanding in the U.S. and worldwide to help more patients and their families. Incannex trades on the Nasdaq Global Market under the symbol IXHL.